In the last 12 months, insiders at NYMOX PHARMACEUTICAL CORP ($NYMXF) filed 3 transactions with the SEC: 3 open-market purchases totaling $54,800 and 0 sales totaling $0. Net insider sentiment: net buying.
NYMOX PHARMACEUTICAL CORP operates in the In vitro & in vivo diagnostic substances industry (Life sciences sector).
Most Active Insiders
- Robinson James George (Director) — 3 transactions totaling $54,800
View all SEC Filings for NYMOX PHARMACEUTICAL CORP (NYMXF).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 25, 2023 | Robinson James George | Director | P | Common Stock | 40000 | $0.45 | 4,742,065.0000 | 90,515,140 | 0.85% | 0.04% |
| April 27, 2023 | Robinson James George | Director | P | Common Stock | 40000 | $0.47 | 4,782,065.0000 | 90,515,140 | 0.84% | 0.04% |
| April 25, 2023 | Robinson James George | Director | P | Common Stock | 40000 | $0.45 | 4,742,065.0000 | 90,515,140 | 0.85% | 0.04% |